Esteroides inhalados para el asma aguda después del alta del servicio de urgencias
Información
- DOI:
- https://doi.org/10.1002/14651858.CD002316.pub2Copiar DOI
- Base de datos:
-
- Cochrane Database of Systematic Reviews
- Versión publicada:
-
- 12 diciembre 2012see what's new
- Tipo:
-
- Intervention
- Etapa:
-
- Review
- Grupo Editorial Cochrane:
-
Grupo Cochrane de Vías respiratorias
- Copyright:
-
- Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Cifras del artículo
Altmetric:
Citado por:
Autores
Contributions of authors
For the 2000 version of this review:
Edmonds ML: initiated the review, wrote the protocol, performed searches, performed quality assessments, entered data and performed analysis, and was primary author of review and updated versions.
Camargo CA Jr: protocol development, methodological input, statistical support and assumed major editorial role.
Brenner BE Jr: protocol development and manuscript review.
Rowe BH: co‐authored protocol, performed selection for inclusion and quality assessment, data extraction and data entry, manuscript review, conversion to RevMan 4 and assigned editor for Cochrane Airways Review Group.
In the 2012 revision of this review Milan SJ and Edmonds M independently selected trials for inclusion from initial searches, and Edmonds M selected trials for inclusion from full trial reports. Milan SJ updated the 'Risk of bias' tables for trials already included in the review and similarly for any new trials identified in the update and they were checked by Edmonds M. Milan SJ and Edmonds M also worked jointly on the remaining aspects of the 2012 update. Rowe BH provided design input, manuscript review, and was the assigned editor for the Cochrane Airways Review Group.
Sources of support
Internal sources
-
Department of Emergency Medicine, University of Alberta, Edmonton, AB, Canada.
-
NHS Research and Development, UK.
-
National Institute of Health Research (SJM), UK.
External sources
-
HL‐03533 NIH (CA Camargo Jr), USA.
-
Canadian Institutes of Health Research (CIHR), Ottawa, ON (BH Rowe), Canada.
Declarations of interest
The authors who have been involved in this review have done so without any known conflicts of interest. Drs. Rowe, Brenner and Camargo were involved as lead investigators in the primary studies of oral corticosteroid plus ICS versus oral corticosteroid alone. Drs. Camargo, Rowe and Brenner have received unrestricted educational grants for research from Astra, Boehringer‐Ingelheim, Forest, Glaxo Wellcome, Merck and Sepracor. However, none of the authors is considered a paid consultant by any pharmaceutical company that produces ICS agents.
Acknowledgements
The original version of this review in 2000 included the following acknowledgment: the authors wish to acknowledge the assistance of Stephen Milan, Anna Bara and Jane Dennis of the Cochrane Airways Review Group. Several drug companies and authors provided additional information about published and unpublished studies as well. Jennifer Haddon (Astra Pharma, Canada) provided additional data and other references for studies. Dr Elisabeth Stahl (Astra Draco AB) and Toni Maslen (Glaxo Wellcome UK) both provided additional information about an included study. Dr B. Volovitz provided additional information as well as additional data analysis. Glaxo Wellcome UK provided information about their sponsored studies. Dr Mark Levy suggested an additional study for inclusion.
In 2012 the authors responsible for the update of this review would particularly like to acknowledge the excellent support and assistance from Emma Welsh, Liz Stovold and Emma Jackson of the Cochrane Airways Review Group, together with the greatly appreciated guidance from Chris Cates (Cochrane Airways Review Group Co‐ordinating Editor). We would also like to thank Alexey Seniukovich and Taixiang Wu for the translation of potentially relevant trials. We are also most grateful to Jos Verbeek for his assistance with the translation of a clinical trial. The support provided by librarians Judith Scammel, Jane Appleton and Hilary Garrett at St Georges University London is also greatly appreciated.
Version history
| Published | Title | Stage | Authors | Version |
| 2012 Dec 12 | Inhaled steroids for acute asthma following emergency department discharge | Review | Marcia L Edmonds, Stephen J Milan, Barry E Brenner, Carlos A Camargo Jr, Brian H Rowe | |
| 2000 Jul 24 | Inhaled steroids for acute asthma following emergency department discharge | Review | Marcia Edmonds, Barry E Brenner, Carlos A Camargo, Brian H Rowe | |
Differences between protocol and review
In the 2012 update of this review heterogeneity was assessed mainly in relation to I2. Risk of bias was assessed in accordance with Chapter 8 of the Cochrane Handbook for Systematic Reviews of Interventions (Higgins 2011).
